Metabolism Disorder TRIZ Cases

Amide-linked lipophilic substituents on GLP-1 derivatives resist DPP-IV enzymolysis, extending half-life and reducing injection frequency.

Cortisol and IL-6 antagonists modulate systemic immune responses to prevent acute respiratory failure.

Conjugating a fatty acid to a shortened exenatide sequence reduces renal clearance burden while maintaining blood glucose lowering efficacy.

Diacylglycerol oil at 5 weight percent dissolves tetracyclic triterpene alcohols, preventing crystal precipitation and rough texture in cooked rice.

Multi-step chromatography removes serum contaminants and organic solvents from recombinant human iduronate 2-sulfatase, ensuring high purity.

A linear polyethylenimine copolymer with imidazole groups enhances transfection efficiency.

Gaboxadol lowers HbA1c via GABAA receptor modulation, resolving the trade-off between glycemic control and adverse effects in diabetes treatment.

An antigen binding protein targets the gastric inhibitory peptide receptor to block biological activity and lower circulating cortisol concentrations.

Optimized bulk polymerization minimizes residual monomer contaminants in styrene-maleic anhydride copolymers, eliminating complex purification steps.

Linking insulin to an immunoglobulin Fc region via a non-peptidyl polymer extends serum half-life while maintaining in vivo activity.

A specific ratio of triple and double glycosylated tissue kallikrein-1 polypeptides enhances glucose infusion rates.

Concurrent addition of trypsin and carboxypeptidase B minimizes undesired byproduct formation during insulin precursor conversion.

A specific meal plan, exercise regimen, and natural supplements normalize metabolism to reverse Type 2 diabetes.

Autologous fecal transplants re-establish immune tolerance to halt autoimmune tissue destruction without complex immunosuppressive therapies.

Engineered FGF21 mutant polypeptides resolve short in vivo half-life bottlenecks by introducing stability-enhancing mutations and fusion constructs.

Temperature-sensitive chitosan decomposition enzymes break down the gel matrix to regulate drug release rates and reduce injection frequency.

A novel dapagliflozin synthesis route uses specific protecting groups to achieve high purity.

Chlorogenic acid and short chain fatty acids induce ketogenesis to bypass dietary restrictions and sustain metabolic health.

Tempol nitroxide antioxidant modulates gene expression to improve glucose control reliability while bypassing complex genetic therapy mechanisms.

Cation-insulin conjugates in spray dried formulations reduce mitogenicity while maintaining bioavailability for oral delivery.

Topical calreticulin resolves healing defects in chronic diabetic wounds by inducing macrophage migration and enhancing granulation tissue formation.

Modified apelin peptides prevent receptor desensitization to extend therapeutic duration for cardiovascular disorders.

SerpinB1 mediates beta cell proliferation to increase functional mass despite insulin resistance.

Phospho-specific antibodies detect Xom Ser140/144 phosphorylation to assess LEF1/TCF pathway activity and improve cancer prognosis accuracy.

Fc alpha molecules activate CD89 receptors to induce neutrophil apoptosis, resolving chronic inflammation and tissue damage in autoimmune disorders.

Mannide monooleate compounds restore membrane plasticity in non-adipocyte cells, resolving cellular toxicity caused by saturated fatty acid accumulation.

Direct sGC binding avoids nitrate-induced tolerance, sustaining therapeutic efficacy for cardiovascular treatment.

Modified peptides reduce body weight and improve metabolic profiles while maintaining stable glycemic control.

TDMQ20 tetradentate chelator removes hepatic copper via selective binding, resolving adverse effects from poor metal selectivity in existing therapies.

Incorporating a volatile additive into the lyophilization formulation reduces reconstitution time while maintaining storage stability.

Triaryl compounds activate telomerase to increase pancreatic beta-cell mass, addressing the inability of current treatments to restore functional tissue.

An active physiological system combines dietary fibers and vegetable fats to slow nutrient absorption.

Segmented chain assembly with simultaneous folding achieves high purity relaxin-2 despite low yield constraints.

Segmented IL-3 peptides block RANKL-RANK signaling to suppress osteoclast formation while maintaining stability for therapeutic use.

Anti-PCSK9 antibodies bind PCSK9 to block LDL receptor degradation, reducing atherosclerosis risk.

Conjugated insulin in a hydrated polymer matrix maintains stable plasma levels without burst effects.

Segments Coenzyme A into stable phosphopantetheine to resolve industrial availability limits while reducing residual cardiovascular risk.

Composite herbal extracts modulate lipid metabolism pathways to reduce body weight gain without adverse side effects from synthetic medications.

A Peucedanum japonicum extract containing khellactone esters inhibits cyclic AMP phosphodiesterase activity to reduce body fat.

Stress resistance increasing compounds modulate FOXO3, NRF2, and mTOR pathways to enhance cellular protection.

Alanylglutamine dipeptides relieve muscle pain and lassitude by improving stability compared to glutamine supplements.

Macro-capsules solve retrievability and dose limits by using cellulose sulfate barriers in the omentum.

Botulinum toxin blocks pathological substance P release in sensory ganglia, restoring glucose control without motor side effects.

Inhibiting HIF hydroxylases stabilizes HIFα to selectively reduce visceral fat while preserving muscle mass.